Lyduine Collij

Clinical neuroscientist; Postdoctoral researcher Lund University; BioFINDER; AMYPAD European IMI project; amyloid PET imaging; disease heterogeneity

[AMYPAD @IMI_AMYPAD]

The @IMI_AMYPAD Prognostic and Natural History Study has had a successful year💥

Visit our website to get an overview of the data accessibility, a snapshot of 2024, and a glimpse into the future with the #EuroPAD community ⤵️

https://t.co/CR5fVlDpdK

[Lyduine Collij @LECollij]

@bettytijms @AlzheimerAms @AmsNeuroscience @amsterdamumc Wow, what an achievement! Congrats Betty! 👏🥳

[Lyduine Collij @LECollij]

📢New paper out❗️We present the context-of-use of the robust and generalizable Centiloid scale in the clinical routine 🏥 and in the context of DMTs💊. What a timing after the amazing news from last Thursday on Lecanemab!🤓

Academia-EFPIA collaborations were key!
@IMI_AMYPAD

[AMYPAD @IMI_AMYPAD]

🎯@IMI_AMYPAD researchers have published context-of-use recommendations for the implementation of the Centiloid scale in clinical practice.

@alzdemjournals @IHIEurope @LECollij @MehrnazShekari @FBarkhof @DavidVallez @JuandoGispert

To know more, visit⤵️
https://t.co/6EAkJeBgvX

[Lyduine Collij @LECollij]

Does amyloid-PET quantification really support visual assessment❓ Yes❗
In this latest @IMI_AMYPAD paper, we show how the value of quant in challenging clinical cases 🧐
Check out the paper below 👇

@VGaribotto @SilviaMorbelli @FBarkhof

[AMYPAD @IMI_AMYPAD]

📢NEW @IMI_AMYPAD paper out demonstrating the value of quantification to support visual assessment in a clinical study enriched for challenging amyloid PET cases.

@JournalofNucMed @LECollij @DavidVallez @VGaribotto @JuandoGispert @FBarkhof 👏

https://t.co/0xAExRDYwl

[Lyduine Collij @LECollij]

Honored to have been awarded the @alzheimernl Research Talent Award! 🤓 Extremely proud for my work to be recognized to have scientific and societal impact 🏥

Thanks to everyone who made this work possible 🙏
@FBarkhof @IMI_AMYPAD @AlzheimerAms @RikOssenkoppele @OskarHansson9

[Gemma Salvadó @gesalbla]

Today I will be presenting "Use of plasma p-tau217 to identify Aβ-positive cognitively unimpaired participants for clinical trials: A multicohort stud" at @CTADconference (OC-29, 4:40pm CEST).

[Lyduine Collij @LECollij]

@gesalbla Completely agree Gemma! The random interactions we have during the day always inspire me the most! 🤞🏻

[AMYPAD @IMI_AMYPAD]

🙌Pleased to be part of the first @eumind_congress this week 🇫🇷

Special shout-out to Leo Pieperhoff & @LECollij for showcasing the @IMI_AMYPAD project and its Prognostic and Natural History Study dataset available through the @AlzData #ADWorkbench⤵️
https://t.co/LpsuSny0xH

[AMYPAD @IMI_AMYPAD]

We had a fantastic day yesterday at the @eumind_congress! If you're attending #EUMind2024, don’t miss @LECollij's presentation today on 'From @IMI_AMYPAD to #EuroPAD – creating a multi-cohort preclinical database to model AD disease trajectories.' #EUMIND

[Lyduine Collij @LECollij]

@gesalbla Thanks Gemma! 🥰

[BioFINDER @biofinder_study]

🚨New publication led by @LECollij ‼️
Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer’s disease” shows the exacerbating effects of a-synuclein co-pathology in Alzheimer's disease. Now published in @NatureComms !
https://t.co/Vy1rRbVsiS

[Alzheimer's Disease Data Initiative @AlzData]

The @IMI_AMYPAD study is advancing research, aiming to improve #Alzheimer’s modelling efforts. This dataset includes cognition data, disease biomarkers, genetic and environmental risk factors, and other relevant variables. https://t.co/146oGN8zV1

[Lyduine Collij @LECollij]

For all the Europeans that don't understand ounces at the #AAIC2024 😂👌

[AMYPAD @IMI_AMYPAD]

#AAIC24 started this morning with an interactive educational session on Amyloid PET Quantification. Thanks to all speakers & delegates🤗

👉Today stop by Poster 88788 from @emmaluckettneu1 "Associations between AD polygenic risk scores & global amyloid deposition in @IMI_AMYPAD"

[Lyduine Collij @LECollij]

@SEMastenbroek @DrFerreiraD @OskarHansson9 @FBarkhof @RikOssenkoppele Fabulously done, as usual!! 😎

[Lyduine Collij @LECollij]

New preprint from @IMI_AMYPAD out📢 Using a prospective study design, we showed that quantification🔢 of amyloid-PET scans🧠improves the visual assessment agreement🧐and confidence 💪between 5 readers. The study was enriched for challenging cases🤔.
https://t.co/Yp5cgrx4s0

[Lyduine Collij @LECollij]

Big thanks to @GEHealthCare and @LifeMolecular for supporting this important and valuable initiative!

[Lyduine Collij @LECollij]

It's a wrap🤩! What a great two days again at the #EuroPAD meeting, a growing European 🇪🇺 collaboration of several cohorts including @IMI_EPAD @IMI_AMYPAD. This year, we kicked off with two workshops �� on advances in PET and MR imaging 🩻 Thanks @LuigiLorenzini1 @DavidVallez!

[Lyduine Collij @LECollij]

And of course, a great symposium dinner in the center of Amsterdam

[Lyduine Collij @LECollij]

Also several new partners joined this year!